Gilead Sciences (GILD) Stock Drops Despite Q1 Beat on Massive Acquisition Charges

Gilead Sciences (GILD) stock dropped ~2% after cutting full-year EPS guidance despite beating Q1 estimates, driven by $11.5B in acquisition charges.

The post Gilead Sciences (GILD) Stock Drops Despite Q1 Beat on Massive Acquisition Charges appeared first on Blockonomi.